e-learning
resources
Munich 2006
Tuesday 05.09.2006
Hospital-acquired pneumonia: from inflammation to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Ventilator-associated pneumonia: risk factors for antimicrobial-resistant causative pathogens
M. H. Ruiz, J. A. Guerrero, C. M. Romero (Santiago, Chile)
Source:
Annual Congress 2006 - Hospital-acquired pneumonia: from inflammation to treatment
Session:
Hospital-acquired pneumonia: from inflammation to treatment
Session type:
Poster Discussion
Number:
4501
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. H. Ruiz, J. A. Guerrero, C. M. Romero (Santiago, Chile). Ventilator-associated pneumonia: risk factors for antimicrobial-resistant causative pathogens. Eur Respir J 2006; 28: Suppl. 50, 4501
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis
Source: Eur Respir J 2015; 45: 1353-1363
Year: 2015
Pulmonary disease as a risk factor for community-acquired pneumonia caused by multiple pathogens, including
Streptococcus pneumoniae
Source: Eur Respir J 2001; 18: Suppl. 33, 502s
Year: 2001
Incidence and risk factors of MRSA pneumonia
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
Long term survival and risk factors for gram-negative bacillary aetiology in patients with community-acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Source: Eur Respir J 2004; 24 : 779-785
Year: 2004
Treatment failure of community-acquired pneumonia: risk factors and consequences
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012
The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Factors associated with hospital mortality in community-acquired legionellosis in France
Source: Eur Respir J 2012; 39: 963-970
Year: 2012
Is health care-associated pneumonia itself a predisposing factor for multi-drug resistant organisms?
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Nosocomial superinfection is one of the principal cause of mortality in severe community-acquired pneumonia
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008
Levofloxacin non-susceptible
streptococcus pneumoniae
in community-acquired respiratory infection; prevalence and risk factors
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Risk factors of paediatric community-acquired pneumonia
Source: Eur Respir J 2011; 37: 724-725
Year: 2011
Risk factors for infections with potentially resistant pathogens in patients in a pneumological intensive-care-unit
Source: Eur Respir J 2002; 20: Suppl. 38, 476s
Year: 2002
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Source: Eur Respir J 2007; 30: 307-313
Year: 2007
Risk factors of nosocomial pneumonia in multiple trauma patients
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
Early mortality in patients with community-acquired pneumonia: causes and risk factors
Source: Eur Respir J 2008; 32: 733-739
Year: 2008
Risk factors of community-acquired pneumonia in children
Source: Eur Respir J 2010; 36: 1221-1222
Year: 2010
The main risk factors of the community-acquired pneumonia delayed course
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept